Sunil Raikar

Has grant

Emory University and Children's Healthcare of Atlanta

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Microfluidic platforms to generate 'off-the-shelf' fratricide-resistant CAR T cells for T-cell malignancies

Open Date: 2020-12-10

Close Date: 2023-11-30

Grant: Close

Gamma delta T-cell immunotherapy for T-cell acute lymphoblastic leukemia

Open Date: 2020-04-01

Close Date: 2025-03-31

Grant: Close

Novel chimeric antigen receptors for T-cell malignancies

Open Date: 2017-09-01

Close Date: 2020-06-01

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sunil Raikar

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas

MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity

Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines

Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow

Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next‐generation sequencing and dual‐fusion FISH analysis

Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia

PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity

Mixed phenotype acute leukemia in a child associated with a NUP98‐NSD1 fusion and NRAS p.Gly61Arg mutation

Interleukin-37 improves T-cell-mediated immunity and chimeric antigen receptor T-cell therapy in aged backgrounds

Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

Collaborators (5)

Melinda Pauly

Erik Dreaden

Douglas Graham

Jeremy Boss

Shireen Ganapathi

Make your next move.